—
C+
C+ The full Closelooknet — membership. Open the C+ overview

Pacific Biosciences of California（PACB）— 技术面状态

数据截至2026-10-14 — 每个交易日晚间对全部覆盖范围重新计算。Closelook研究日记，不构成投资建议。

Recovery attempt under the 200-day

Trades +26.1% vs the 50-day and +24.8% vs the 200-day average, 42.2% below the 52-week high and +86% off the 52-week low. Computed from daily closes.

均线状态

相关页面： PACB图表与概览 · 信号看板

FAQ · from the current data · as of 2026-10-14

Quick answers

PACB当前的Closelook信号是什么？

Recovery attempt under the 200-day — Trades +26.1% vs the 50-day and +24.8% vs the 200-day average, 42.2% below the 52-week high and +86% off the 52-week low. Computed from daily closes.（截至2026-10-14；信号看板每个交易日晚间对全部覆盖范围重新计算。研究日记读数，不构成投资建议。）

PACB目前是否位于50日和200日均线上方？

截至2026-10-14，Pacific Biosciences of California位于50日均线上方（+26.1%），200日均线上方（+24.8%）；距20日均线-1%。

PACB距52周高点有多远？

截至2026-10-14，低于52周高点42.2%，高于52周低点86%。

Related in the Closelooknet universe

then Medical Devices. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.